IPO Profile: Avalanche Biotechnologies Inc

Venrock saw a return of 0.6x on its investment

1 August 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.